Product name:  lenvatini Mesylate

CAS No.:  857890-39-2

MF: C22H23ClN4O7S

M.W.:  522.95862g/mol

Capacity:  100KG/M 

Usage: Cancer/tumor


■ Description

DescriptionLevatinib mesylate is the mesylate of levatinib, which is a multi-target tyrosine kinase inhibitor that may act on various cancers. Lenvatini Mesylate (E7080) is a synthetic and orally active inhibitor of tyrosine kinase, which can inhibit vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), and platelet derived growth factor receptor (PDGFR) α)Stem cell factor receptors (Kit (c-Kit)) are rearranged during transfection (RET (c-RET)). Levatinib mesylate has potential anti-tumor activity.

■ Message